Drug Manufacturers—General Stocks
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2166 |  MAZE Maze Therapeutics, Inc. - Common Stock | 25.88 USD | -1.41% | -4.43% | +6.68% | -42.53% | 1.44 B USD | ||
| 2169 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 29.85 USD | -3.27% | -10.44% | -31.14% | +13.97% | 1.43 B USD | ||
| 2823 |  CBIO Crescent Biopharma, Inc. - Common Stock | 14.12 USD | +4.67% | -2.49% | -28.14% | +15.93% | 524.47 M USD | ||
| 3004 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 7.50 USD | -0.53% | -0.66% | -29.38% | -56.01% | 406.24 M USD | ||
| 3388 |  AMRN Amarin Corporation plc - American Depositary Shares, each repre | 11.99 USD | -0.25% | -7.77% | -15.98% | -22.94% | 253.26 M USD | ||
| 3397 |  UPB Upstream Bio, Inc. - Common Stock | 4.55 USD | -1.30% | -6.76% | -22.35% | -77.02% | 249.21 M USD | ||
| 3424 |  QTTB Q32 Bio Inc. - Common Stock | 8.09 USD | +1.25% | -3.11% | -26.45% | +129.83% | 240.83 M USD | ||
| 3863 |  PLYX Polaryx Therapeutics, Inc. - Common Stock | 2.00 USD | -4.31% | -2.44% | -2.91% | -95.56% | 99.69 M USD | ||
| 3886 |  OKUR OnKure Therapeutics, Inc. - Class A Common Stock | 2.30 USD | -2.13% | -10.51% | -32.15% | -6.12% | 93.14 M USD | ||
| 3965 |  PTHS Pelthos Therapeutics Inc. Common Stock | 20.80 USD | -2.58% | +1.41% | -9.88% | -14.79% | 79.63 M USD | ||
| 3990 |  OSTX OS Therapies Incorporated Common Stock | 1.62 USD | +5.88% | -0.61% | -12.90% | +40.87% | 74.72 M USD | ||
| 4178 |  EXOZ eXoZymes Inc. - Common Stock | 5.33 USD | -3.79% | -7.47% | -13.75% | -45.05% | 49.47 M USD | ||
| 4183 |  VBIO Valion Bio, Inc. - Common stock | 2.21 USD | +0.91% | -13.33% | -7.14% | +84.17% | 49.04 M USD | ||
| 4193 |  DWTX Dogwood Therapeutics, Inc. - Common Stock | 1.41 USD | -1.40% | -7.84% | -27.32% | -53.00% | 47.93 M USD | ||
| 4312 |  IBO Impact BioMedical, Inc. Common Stock | 4.12 USD | -9.25% | -21.82% | +758.33% | +836.36% | 35.20 M USD | ||
| 4378 |  MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.70 USD | -1.41% | -4.11% | -11.39% | -48.15% | 29.42 M USD | ||
| 4415 |  SCLX Scilex Holding Company - Common Stock | 2.96 USD | -15.19% | -33.03% | -42.97% | -63.59% | 25.14 M USD | ||
| 4734 |  APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 5.43 USD | -22.09% | +32.44% | +136.09% | +314.50% | 8.19 M USD | ||
| 4786 |  MDCX Medicus Pharma Ltd. - Common Stock | 0.10 USD | -37.50% | -37.50% | -41.18% | -91.53% | 6.32 M USD | ||
| 4829 |  QCLS Q/C Technologies, Inc. - Common Stock | 0.64 USD | +1.59% | -17.95% | -63.22% | -83.42% | 5.24 M USD |
뉴스 Drug Manufacturers—General Stocks
러시아, 시베리아에서 두 번째 발병 사례 보도 부인 - 블룸버그
서밋 테라퓨틱스, 아스트라제네카 및 다이이치 산쿄, 다양한 종양 유형에서 이보네시맙과 TROP2 표적 ADC 다트로웨이 병용 임상시험 협력 발표···3상 1차 치료 삼중음성 유방암 연구부터 시작
포그혼 테라퓨틱스, 일라이 릴리와 계약 종료 후 파이프라인 전환
도널드 트럼프와 캐시 우드가 동일하게 투자한 32개 주식···일부는 놀라운 종목도
인비비드, 코로나19 항체 치료제 FDA 신속 승인 신청 절차 발표
오르가논 캐나다, 중등도에서 중증 아토피 피부염 치료제 ‘엔두브라’ 출시 발표
화이자 2026년 2분기 실적 발표 컨퍼런스콜 전문
Gainers Drug Manufacturers—General Stocks
 LIMNW Liminatus Pharma, Inc. - Warrants | 0.0497 | +34.32% |
 MANE Veradermics, Incorporated Common Stock | 126.68 | +13.94% |
OSTX OS Therapies Incorporated Common Stock | 1.62 | +5.88% |
 KAPA Kairos Pharma, Ltd. Common Stock | 0.93 | +5.68% |
CBIO Crescent Biopharma, Inc. - Common Stock | 14.12 | +4.67% |
 GENB Generate Biomedicines, Inc. - Common Stock | 13.99 | +3.10% |
QCLS Q/C Technologies, Inc. - Common Stock | 0.64 | +1.59% |
 CGON CG Oncology, Inc. - Common stock | 63.26 | +1.41% |
Losers Drug Manufacturers—General Stocks
MDCX Medicus Pharma Ltd. - Common Stock | 0.10 | -37.50% |
APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 5.43 | -22.09% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0319 | -16.05% |
SCLX Scilex Holding Company - Common Stock | 2.96 | -15.19% |
IBO Impact BioMedical, Inc. Common Stock | 4.12 | -9.25% |
 PPCB Propanc Biopharma, Inc. - Common Stock | 0.47 | -6.00% |
 DCOY Decoy Therapeutics Inc. - Common Stock | 1.52 | -5.59% |
 VIVS VivoSim Labs, Inc. - Common Stock | 0.18 | -5.26% |